[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Qiagen N.V. Qiagen partners with ID Solutions for oncology research expansion. Barclays initiates Qiagen stock with an overweight rating, boosting investor optimism. ### About Qiagen N.V. Qiagen N.V. is a company providing sample and assay technologies for molecular diagnostics and life sciences. ### Price: $ [#](/topic/$qiade/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/close.tsv) The price action is likely driven by investor optimism due to positive social sentiment around partnerships and product development, and the initiating of Qiagen stock with an overweight rating by Barclays. **1-Year High**: $XX on 2025-01-22 **1-Year Low**: $XXXXX on 2025-04-10 ### AltRank: undefined [#](/topic/$qiade/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/alt_rank.tsv) Qiagen N.V. is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXX **1-Year High**: XXXXX on 2024-10-21 **1-Year Low**: XXX on 2025-02-27 ### Galaxy Score: XX [#](/topic/$qiade/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XX on 2025-01-17 **1-Year Low**: XX on 2025-02-01 ### Engagements: XXXXXX [#](/topic/$qiade/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/interactions.tsv) **Current Value**: XXXXXX **Daily Average**: XXXXX **1 Week**: XXXXXXX -XX% **1 Month**: XXXXXXX +24% **6 Months**: XXXXXXXXX +72% **1 Year**: XXXXXXXXX +48% **1-Year High**: XXXXXX on 2025-04-15 **1-Year Low**: XXX on 2024-11-03 | Social Network | X | Reddit | TikTok | YouTube | | -------------- | - | ------ | ------ | ------- | | Engagements | XXX | XX | XXX | XXXXX | ### Mentions: XX [#](/topic/$qiade/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Month**: XXX -XX% **6 Months**: XXXXX +2% **1 Year**: XXXXX +165% **1-Year High**: XXX on 2025-07-02 **1-Year Low**: X on 2024-10-20 | Social Network | X | Reddit | TikTok | YouTube | | -------------- | - | ------ | ------ | ------- | | Mentions | XX | XX | XX | XX | ### Creators: XX [#](/topic/$qiade/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Qiagen N.V. in the last XX hours which is down XXXX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXX +3.20% **1 Year**: XXX +125% **1-Year High**: XXX on 2025-07-31 **1-Year Low**: X on 2024-10-20 The most influential creators that mention Qiagen N.V. in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@qiagendigitalinsights](/creator/youtube/qiagendigitalinsights) | X | XXXXX | X | XXXXX | | [@qiagen](/creator/youtube/qiagen) | X | XXXXXX | X | XX | | [@joellynnn_](/creator/tiktok/joellynnn_) | X | XXXXXX | X | XX | | [@QIAGEN](/creator/twitter/QIAGEN) | X | XXXXXX | XX | XX | | [@QIAGENBiox](/creator/twitter/QIAGENBiox) | X | XXXXX | X | XX | | [@boston](/creator/youtube/boston) | X | XXXXX | X | X | | [@PathReDCongress](/creator/twitter/PathReDCongress) | X | XXX | X | X | [View More](/list/creators/$qiade/100) ### Sentiment: XX% [#](/topic/$qiade/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XX% +2% **6 Months**: XX% +3% **1 Year**: XX% -X% **1-Year High**: XXX% on 2024-11-18 **1-Year Low**: XX% on 2024-11-10 **Most Supportive Themes** - **Partnerships and Expansions:** (45%) Qiagen's new commercial partnership with ID Solutions to expand dPCR assays for oncology research is driving positive sentiment. - **Training and Development Programs:** (30%) Qiagen's involvement in training programs, including fellowships in Africa and digital PCR training, is being well-received. - **Product Development and Innovation:** (15%) Advancements in long-read sequencing and molecular assay development create excitement and anticipation for upcoming product launches. **Most Critical Themes** - **Packaging Concerns and Research Discussion:** (1%) Users are critiquing Qiagen's eco-friendly packaging claims. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | X% | XXX | X% | X | X% | | Reddit | XX | X% | XX | X% | XX | X% | | TikTok | XX | X% | XXX | X% | X | X% | | YouTube | XXXXX | XX% | XXXXX | XX% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XX | X% | ### Market Cap: $undefined [#](/topic/$qiade/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$qiade/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXX on 2025-01-22 **1-Year Low**: $XXXXXXXXXXXXX on 2025-03-11 **Top assets mentioned** In the posts about Qiagen N.V. in the last XX hours [Qiagen NV (QGEN)](/topic/$qgen) [Swap (XWP)](/topic/$xwp) [GeneDx Holdings Corp. Class A Common Stock (WGS)](/topic/$wgs) [Super Micro Computer, Inc. Common Stock (SMCI)](/topic/$smci) [Advanced Micro Devices (AMD)](/topic/advanced-micro-devices) [Amgen, Inc. (AMGN)](/topic/$amgn) [Innovative Solutions & Support (ISSC)](/topic/$issc) **Top topics mentioned** In the posts about Qiagen N.V. in the last XX hours [protocol](/topic/protocol), [dna](/topic/dna), [faster](/topic/faster), [$qgen](/topic/$qgen), [applications](/topic/applications), [genome](/topic/genome), [the only](/topic/the-only), [germany](/topic/germany), [work for](/topic/work-for), [boston](/topic/boston), [hahaha](/topic/hahaha), [curated](/topic/curated), [saving](/topic/saving), [unlock](/topic/unlock), [university of](/topic/university-of), [realtime](/topic/realtime), [south africa](/topic/south-africa), [botswana](/topic/botswana), [kenya](/topic/kenya), [namibia](/topic/namibia), [capabilities](/topic/capabilities), [filter](/topic/filter), [ipa](/topic/ipa), [denmark](/topic/denmark), [acquisition](/topic/acquisition), [abstract](/topic/abstract), [prep](/topic/prep), [up the](/topic/up-the), [arms](/topic/arms), [$190genome](/topic/$190genome), [phd](/topic/phd), [bleach](/topic/bleach), [asia](/topic/asia), [debt](/topic/debt), [tax bracket](/topic/tax-bracket), [$xwp](/topic/$xwp), [loading](/topic/loading), [all the](/topic/all-the), [lauren](/topic/lauren), [unboxing](/topic/unboxing), [yan](/topic/yan), [slay](/topic/slay), [lang](/topic/lang), [po](/topic/po), [kaya](/topic/kaya), [nico](/topic/nico), [mi](/topic/mi), [palm beach](/topic/palm-beach), [tb](/topic/tb), [investment](/topic/investment), [longterm](/topic/longterm), [instagram](/topic/instagram), [ais](/topic/ais), [breaking news](/topic/breaking-news), [world record](/topic/world-record), [$bimpa](/topic/$bimpa), [united states](/topic/united-states), [liquid](/topic/liquid), [cape town](/topic/cape-town), [malaysia](/topic/malaysia), [$wgs](/topic/$wgs), [francis](/topic/francis), [targets](/topic/targets), [built in](/topic/built-in), [jordan](/topic/jordan), [future of](/topic/future-of), [plants](/topic/plants), [membrane](/topic/membrane), [beginner](/topic/beginner), [money](/topic/money), [hosted](/topic/hosted), [$smci](/topic/$smci), [zalando](/topic/zalando), [advanced micro devices](/topic/advanced-micro-devices), [stocks technology](/topic/stocks-technology), [$amgn](/topic/$amgn), [companion](/topic/companion), [employees](/topic/employees), [unity technologies](/topic/unity-technologies), [df](/topic/df), [number of](/topic/number-of), [$issc](/topic/$issc), [integration](/topic/integration), [behind the](/topic/behind-the) ### Top Social Posts [#](/topic/$qiade/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "H/t to an anonymous commenter for pointing out a QIAGEN PR that claims $190/genome for SBX World record for human genome sequencing achieved by Roche and Franklin by QIAGEN - Bioinformatics Software QIAGEN Digital Insights" [X Link](https://x.com/OmicsOmicsBlog/status/1979872048655552701) [@OmicsOmicsBlog](/creator/x/OmicsOmicsBlog) 2025-10-19T11:27Z 10K followers, XXX engagements "Harvard and Stanford students tell me their professors don't understand the kits you can buy from Fisher Scientific or QIAGEN and the courses are outdated. If elite schools can't keep up the credential arms race is over. Self-learning is the only way now" [X Link](https://x.com/Feline_Father_/status/1979413653750227277) [@Feline_Father_](/creator/x/Feline_Father_) 2025-10-18T05:06Z XXX followers, XXX engagements "BREAKING NEWS literally. See how Roche broke the #Guinness World Record for #sequencing using their SBX chemistry and Franklin by QIAGEN in collaboration with Boston Childrens Hospital and Broad Clinical Labs 👉" [X Link](https://x.com/QIAGENBiox/status/1979276201261941004) [@QIAGENBiox](/creator/x/QIAGENBiox) 2025-10-17T19:59Z 9572 followers, XX engagements "Naveris executive chairman founder and chief science & technology officer Piyush Gupta PhD joins a roundtable discussion on Evolving Technologies for Molecular Residual Disease Testing in Solid Tumors Perspectives on Platforms and Clinical Utility sponsored by @QIAGEN. On October XX at 12:00pm Eastern Dr. Gupta and other clinical oncology and biotech experts will discuss evolving best practices for MRD testing in solid tumors reflect on clinical questions that future studies will need to answer and explore how different technologies like dPCR and next-gen sequencing may be better 'fit for" [X Link](https://x.com/Naveris_inc/status/1979272144556114091) [@Naveris_inc](/creator/x/Naveris_inc) 2025-10-17T19:43Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Qiagen N.V.
Qiagen partners with ID Solutions for oncology research expansion. Barclays initiates Qiagen stock with an overweight rating, boosting investor optimism.
About Qiagen N.V.
Qiagen N.V. is a company providing sample and assay technologies for molecular diagnostics and life sciences.
Price: $ #
Price 24-Hour Time-Series Raw Data
The price action is likely driven by investor optimism due to positive social sentiment around partnerships and product development, and the initiating of Qiagen stock with an overweight rating by Barclays.
1-Year High: $XX on 2025-01-22
1-Year Low: $XXXXX on 2025-04-10
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Qiagen N.V. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2024-10-21
1-Year Low: XXX on 2025-02-27
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-01-17
1-Year Low: XX on 2025-02-01
Engagements: XXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXX +24%
6 Months: XXXXXXXXX +72%
1 Year: XXXXXXXXX +48%
1-Year High: XXXXXX on 2025-04-15
1-Year Low: XXX on 2024-11-03
| Social Network | X | TikTok | YouTube | |
|---|---|---|---|---|
| Engagements | XXX | XX | XXX | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +2%
1 Year: XXXXX +165%
1-Year High: XXX on 2025-07-02
1-Year Low: X on 2024-10-20
| Social Network | X | TikTok | YouTube | |
|---|---|---|---|---|
| Mentions | XX | XX | XX | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Qiagen N.V. in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXX +3.20%
1 Year: XXX +125%
1-Year High: XXX on 2025-07-31
1-Year Low: X on 2024-10-20
The most influential creators that mention Qiagen N.V. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @qiagendigitalinsights | X | XXXXX | X | XXXXX |
| @qiagen | X | XXXXXX | X | XX |
| @joellynnn_ | X | XXXXXX | X | XX |
| @QIAGEN | X | XXXXXX | XX | XX |
| @QIAGENBiox | X | XXXXX | X | XX |
| @boston | X | XXXXX | X | X |
| @PathReDCongress | X | XXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +2%
6 Months: XX% +3%
1 Year: XX% -X%
1-Year High: XXX% on 2024-11-18
1-Year Low: XX% on 2024-11-10
Most Supportive Themes
- Partnerships and Expansions: (45%) Qiagen's new commercial partnership with ID Solutions to expand dPCR assays for oncology research is driving positive sentiment.
- Training and Development Programs: (30%) Qiagen's involvement in training programs, including fellowships in Africa and digital PCR training, is being well-received.
- Product Development and Innovation: (15%) Advancements in long-read sequencing and molecular assay development create excitement and anticipation for upcoming product launches.
Most Critical Themes
- Packaging Concerns and Research Discussion: (1%) Users are critiquing Qiagen's eco-friendly packaging claims.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | X% | XXX | X% | X | X% |
| XX | X% | XX | X% | XX | X% | |
| TikTok | XX | X% | XXX | X% | X | X% |
| YouTube | XXXXX | XX% | XXXXX | XX% | X | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2025-01-22
1-Year Low: $XXXXXXXXXXXXX on 2025-03-11
Top assets mentioned In the posts about Qiagen N.V. in the last XX hours
Qiagen NV (QGEN) Swap (XWP) GeneDx Holdings Corp. Class A Common Stock (WGS) Super Micro Computer, Inc. Common Stock (SMCI) Advanced Micro Devices (AMD) Amgen, Inc. (AMGN) Innovative Solutions & Support (ISSC)
Top topics mentioned In the posts about Qiagen N.V. in the last XX hours
protocol, dna, faster, $qgen, applications, genome, the only, germany, work for, boston, hahaha, curated, saving, unlock, university of, realtime, south africa, botswana, kenya, namibia, capabilities, filter, ipa, denmark, acquisition, abstract, prep, up the, arms, $190genome, phd, bleach, asia, debt, tax bracket, $xwp, loading, all the, lauren, unboxing, yan, slay, lang, po, kaya, nico, mi, palm beach, tb, investment, longterm, instagram, ais, breaking news, world record, $bimpa, united states, liquid, cape town, malaysia, $wgs, francis, targets, built in, jordan, future of, plants, membrane, beginner, money, hosted, $smci, zalando, advanced micro devices, stocks technology, $amgn, companion, employees, unity technologies, df, number of, $issc, integration, behind the
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"H/t to an anonymous commenter for pointing out a QIAGEN PR that claims $190/genome for SBX World record for human genome sequencing achieved by Roche and Franklin by QIAGEN - Bioinformatics Software QIAGEN Digital Insights"
X Link @OmicsOmicsBlog 2025-10-19T11:27Z 10K followers, XXX engagements
"Harvard and Stanford students tell me their professors don't understand the kits you can buy from Fisher Scientific or QIAGEN and the courses are outdated. If elite schools can't keep up the credential arms race is over. Self-learning is the only way now"
X Link @Feline_Father_ 2025-10-18T05:06Z XXX followers, XXX engagements
"BREAKING NEWS literally. See how Roche broke the #Guinness World Record for #sequencing using their SBX chemistry and Franklin by QIAGEN in collaboration with Boston Childrens Hospital and Broad Clinical Labs 👉"
X Link @QIAGENBiox 2025-10-17T19:59Z 9572 followers, XX engagements
"Naveris executive chairman founder and chief science & technology officer Piyush Gupta PhD joins a roundtable discussion on Evolving Technologies for Molecular Residual Disease Testing in Solid Tumors Perspectives on Platforms and Clinical Utility sponsored by @QIAGEN. On October XX at 12:00pm Eastern Dr. Gupta and other clinical oncology and biotech experts will discuss evolving best practices for MRD testing in solid tumors reflect on clinical questions that future studies will need to answer and explore how different technologies like dPCR and next-gen sequencing may be better 'fit for"
X Link @Naveris_inc 2025-10-17T19:43Z XXX followers, XX engagements